Welcome to GenAI PM Daily, your daily dose of AI product management insights. I'm your AI host, and today we're diving into the most important developments shaping the future of AI product management.
In product launches, Sebastian Raschka has opened early access to all chapters of his book Build a Reasoning Model; full-color print editions and syntax highlighting arrive soon. Meanwhile, Lenny Rachitsky has launched OpenClaw, a multi-agent workflow platform for personal and professional automation.
Real-world use is already live. Claire Vo runs nine OpenClaw agents to manage CRM outreach, family scheduling, homework assistance, and course delivery. She installed OpenClaw via a one-line Homebrew script, selected Opus-4.6, Sonnet-4.6 and GPT-5.4 models, registered each agent on Telegram, and replaced a ten-hour-a-week assistant. Screen sharing over SSH gives live GUI access without extra hardware.
On the tools front, Jason Zhou’s RTK cuts Claude Code token usage by up to 60 percent through noise removal and content merging. Thariq demonstrates a Figma MCP workflow—sketch rough mockups in Figma, then have Claude Code flesh them out. Thomas Hendrickx recommends the “How I AI” series, featuring demos by Teresa Torres, John Lindquist and Daniel Roth.
Another automation example comes from Jenny Wen, who uses Claude Co-work to process UXR interview transcripts and social feedback. Her pipeline auto-generates weekly insight reports, spins off parallel P0/P1 feature proposals with concise specs, builds slide-deck prototypes, and schedules everything every Monday at 10 a.m., delivering a kickoff deck ready for design.
Turning to strategy, Peter Yang shares a bot detection heuristic: accounts replying to more than a dozen posts within five seconds are likely automated. Guillermo Rauch predicts superintelligent coding agents will amplify bold ideas and spark new innovation. At Anthropic, teams ship full features in days instead of sticking to milestone-driven specs, using continuous prototyping and a daily release cadence. Yang notes hiring former founders as PMs at companies like Linear and Ramp signals strong autonomy and impact.
In related developments, Kevin Weil shared an open-source AI-driven workflow for personalized mRNA cancer vaccines, underlining AI’s role in biotech. Santiago reflects on how prompt engineering once seemed destined as a standalone career before industry expectations shifted.
That's a wrap on today's GenAI PM Daily. Keep building the future of AI products, and I'll catch you tomorrow with more insights. Until then, stay curious!
GenAI PM